Ausper Biopharma Co., Ltd.

This study tests an experimental injection called AHB-137 in 60 adults with chronic hepatitis B who have already been treated with standard antiviral pills. The goal is to see if the injection can clear the hepatitis B surface antigen and keep the virus undetectable after stoppin…

This study tests a new drug called AHB-137 given with either a hepatitis B vaccine or another medicine (pegylated interferon) in people with chronic hepatitis B who are already on standard antiviral pills. The goal is to see if the combination can lower the virus to undetectable …

This study checks if people with chronic hepatitis B who got better with the drug AHB-137 stay virus-free over time. Researchers will follow 200 participants for years to see if the virus stays undetectable. The goal is to understand how long the treatment effect lasts.